FluroTech Announces Debt Settlement Agreement

FluroTech Announces Debt Settlement Agreement

FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") is pleased to announce that it has entered into a debt settlement agreement (the "Debt Settlement Agreement") as of April 30, 2024 with an arm's length creditor (the "Creditor") to settle an outstanding debt in the amount of $136,986 (the "Debt"). The Debt comprises the outstanding balance owed by the Company to the Creditor.

Pursuant to the Debt Settlement Agreement, the Creditor has agreed to subscribe for common shares in the capital of the Company under which the total aggregate amount of the Debt will be satisfied in full and final settlement of the Company through the issuance and delivery of 1,826,480 fully paid common shares (the "Debt Shares") in the capital of the Company (the "Common Shares") with an assigned issue price of $0.075 per Common Share (collectively, the "Shares for Debt Transaction"). The Debt Shares are being issued at a price equal to the price per share issued under the Company's recent bridge financing which was disclosed in a news release dated April 26, 2024, in accordance with the policies of the TSXV.

No new control person of the Company will be created pursuant to the Shares for Debt Transaction.

The Company is proposing to issue the Common Shares pursuant to the Shares for Debt Transaction to preserve cash to fund the Company's proposed "Change of Business" transaction as such term is defined in TSXV Policy 5.2 - Changes of Business and Reverse Takeovers ("Policy 5.2") and as is further described in the Company's press releases dated April 19, 2024 and April 26, 2024. The Common Shares issued pursuant to the Shares for Debt Transaction will be issued pursuant to a prospectus exemption and will be subject to a statutory hold period of four months plus one day from the date of issuance, in accordance with applicable securities legislation.

Final approval of the Shares for Debt Transactions remains subject to approval of the TSXV.

Trading Halt

In accordance with Policy 5.2, the Common Shares are currently halted from trading and are expected to remain halted pending the requirements of Section 2.5 of Policy 5.2 being met.

About FluroTech

FluroTech was incorporated under the Business Corporations Act (Alberta) on May 24, 2018. FluroTech is currently inactive with limited operations and the Common Shares of FluroTech are currently halted on the NEX. FluroTech has no commercial operations and no assets other than cash and is a reporting issuer in the provinces of Alberta and British Columbia.

For further information contact:

Michael Rodyniuk, Chief Executive Officer
FluroTech Ltd.
c/o Borden Ladner Gervais LLP
Centennial Place, 520 3 Ave SW Suite 1900
Calgary, AB T2P 0R3
Attention: Michael Rodyniuk, President & CEO
E-mail: mrod@cafincorp.com

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Information

This press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Any statements that are contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "will", "estimates", "believes", "intends" "expects" and similar expressions which are intended to identify forward-looking information or statements. More particularly and without limitation, this press release contains forward looking statements and information concerning: acceptance of the TSXV of the Shares for Debt Transaction, completion of the proposed "Change of Business" transaction and the timing of completion of the Shares for Debt Transaction. FluroTech cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, assumptions and expectations, many of which are beyond the control of FluroTech, including expectations and assumptions concerning FluroTech, the Transaction, the timely receipt of all required TSXV and regulatory approvals and exemptions (as applicable) and the satisfaction of other closing conditions. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of FluroTech. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

The forward-looking statements contained in this press release are made as of the date of this press release, and FluroTech does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by securities law.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO SELL ANY OF THE SECURITIES DESCRIBED HEREIN IN THE UNITED STATES. THESE SECURITIES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/207440

News Provided by Newsfile via QuoteMedia

TEST:CA
The Conversation (0)
FluroTech Announces Closing of Oversubscribed Private Placement Financing

FluroTech Announces Closing of Oversubscribed Private Placement Financing

FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") is pleased to announce, further to its news release dated April 19, 2024, that it has completed its non-brokered private placement financing of common shares of FluroTech ("Common Shares") at a price of CDN$0.075 per Common Share, which was oversubscribed for aggregate gross proceeds of CDN$1,000,000 (the "Private Placement").

The Private Placement was completed in connection with the proposed business combination of the Company with Great Slave Helicopters 2018 Ltd. as further described in the news releases dated March 11, 2024 and April 19, 2024 (the "Transaction"), which such Transaction is intended to constitute a "Change of Business" of FluroTech, as such term is defined in the policies of the TSX Venture Exchange ("TSXV").

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
FluroTech and GS Heli Announce Execution of Definitive Agreement

FluroTech and GS Heli Announce Execution of Definitive Agreement

FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company"), to be renamed Consolidated Aerospace Finance Corporation ("CAFC") pursuant to the Name Change hereinafter described, and Great Slave Helicopters 2018 Ltd. ("GS Heli") are pleased to announce that further to the news release dated March 11, 2024, the parties, along with 15915074 Canada Inc. ("Subco"), a wholly owned subsidiary of FluroTech, have entered into a definitive agreement dated April 19, 2024 (the "Definitive Agreement") pursuant to the proposed acquisition of GS Heli by FluroTech (the "Transaction"). It is intended that the Transaction will constitute a "Change of Business" of FluroTech, as such term is defined in Policy 5.2 ("Policy 5.2") of the TSX Venture Exchange (the "TSXV"). Additionally, it is intended that the Transaction will constitute a "Reactivation" under the policies of the TSXV and that upon completion of the Transaction (the "Closing") and satisfaction of all conditions of the TSXV, FluroTech as it exists upon completion of the Transaction (the "Resulting Issuer") will have its listing transferred from the NEX board of the TSXV ("NEX") to the TSXV. The Transaction is expected to be completed in Q2 2024.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
OTC:FLURF

FluroTech Exhibits at the Grow Up Conference & Expo

 FluroTech Ltd. (TSXV:TEST, OTCQB:FLURF), (“FluroTech” or the “Company”), an aspiring leader in analytical cannabis and hemp testing technologies, is pleased to be exhibiting at the Grow Up Conference & Expo this Thursday to Saturday at the Scotiabank Convention Center in Niagara Falls, Ontario, Canada. The Grow Up Conference and Expo is focused on the education, collaboration and growth of the cannabis growing industry.

We encourage all conference attendees to stop by booth 1105 to learn more about the Company and to take in a live demo of the CompleTestTM which is available for sale.

Keep reading...Show less
OTC:FLURF

FluroTech Provides Update on Hemp Betas

FluroTech Ltd. (TSXV:TEST, OTCQB:FLURF), (“FluroTech” or the “Company”) is pleased to provide an update on its ongoing hemp beta tests with hemp growers/extractors in the U.S. and Canada who are validating the Company’s CBDA testing protocol.

These hemp growers have been testing nearly daily, in an effort to profile the CBDA development in their crop. In Canada, a limited number of strains of hemp are available to growers and these strains usually contain CBDA at or below 4.5%. This has resulted in robust demand for a testing device that can quantify low concentrations of CBDA. The hemp growers working with the Company have planted several different strains and have been benchmarking the plants based on their CBDA concentrations. They have also expressed a keen interest in benchmarking CBDA development measured throughout the current growing season against future growing seasons.

Keep reading...Show less
TSXV:TEST

FluroTech Provides a Technology Update and Bolsters the Sales Team

FluroTech (TSXV:TEST)(OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to provide a technology update. The Company previously disclosed the pause of sales after the company detected a contamination of certain test kits due to packaging materials. Finding alternative packaging, the issue has been resolved. Extensive testing internally and by beta testers validated the test kits perform with the accuracy and repeatability as intended. The CompleTest’s™ accuracy for CBDa and THCa testing is within a 2% variability range, when compared to reference data. This accuracy exceeds the performance of other competitive alternatives available to producers. In addition to high accuracy, the CompleTest™ consistently demonstrates repeatable results of the same sample.

Keep reading...Show less

Latest Press Releases

Related News

×